Compare CII & EOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | CII | EOI |
|---|---|---|
| Founded | 2004 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Finance/Investors Services |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 963.2M | 805.7M |
| IPO Year | N/A | N/A |
| Metric | CII | EOI |
|---|---|---|
| Price | $23.07 | $20.44 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 78.8K | ★ 83.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | 6.17% | ★ 7.19% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.76 | $14.36 |
| 52 Week High | $19.81 | $18.88 |
| Indicator | CII | EOI |
|---|---|---|
| Relative Strength Index (RSI) | 40.65 | 48.26 |
| Support Level | $23.38 | $20.62 |
| Resistance Level | $23.66 | $21.09 |
| Average True Range (ATR) | 0.27 | 0.23 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 0.00 | 7.25 |
Blackrock Enhanced Cap&Inc Fund, Inc is a closed-end management investment company. Its objective is to provide total return through a combination of current income and capital appreciation. The trust seeks to achieve its investment objective by investing a majority of its total assets in a portfolio of equity securities of U.S. and foreign issuers.
Eaton Vance Enhanced Equity Income Fund offers mutual funds that invest across a wide array of equity, income, and alternative strategies. The primary investment objective of the fund is to provide current income, with a secondary objective of capital appreciation. The company's sector allocation includes: Information Technology, Communication Services, Financials, Consumer Discretionary, Healthcare, Industries, Consumer Staples, Energy, Real Estate, and Materials.